Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Softacort in Chronic Dry Eye Disease
NCT03907865Phase 4Completed
- Sponsor
- Medical University of Vienna
- Start
- Mar 2018
- Primary completion
- Nov 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of hydrocortisone in dry eye disease (DED) (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Conjunctival hyperemia at Day 28. Started Mar 2018; status: completed.
02
Drugs
hydrocortisone
03
Conditions
dry eye disease (DED)
Beyond the preview
Go deeper on NCT03907865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03907865.